Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - elisabeth+barton
High potency recombinant IGF-1 biologic
Optimized IGF-1 isoforms have been developed with improved potency in producing muscle hypertrophy.Problem: Insulin-like growth factor I (IGF-I) is a key regulator of muscle development and growth. However, the complexity of IGF-1 activity is modulated by extensive alternative splicing and glycosylation. Solution: A former Penn researcher, Dr. Elisabeth...
Therapeutics & Vaccines
© 2021. All Rights Reserved. Powered by